Inhibrx shares jump after CEO and insiders add stake
Inhibrx Biosciences shares rose more than 7% on Wednesday following insider purchases, including CEO Mark Lappe adding to his stake.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.